Intellia Therapeutics Inc buy Wolfe Research
Start price
21.04.25
/
50%
€6.94
Target price
21.04.26
€18.30
Performance (%)
7.99%
Price
17.12.25
€7.49
Summary
This prediction is currently active. With a performance of 7.99%, the BUY prediction by Wolfe_Research for Intellia Therapeutics Inc is trending in the right direction. This prediction currently runs until 21.04.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -3.048% | -3.048% |
| iShares Core DAX® | 0.060% | 1.215% |
| iShares Nasdaq 100 | -3.065% | -0.519% |
| iShares Nikkei 225® | -2.094% | -3.066% |
| iShares S&P 500 | -1.657% | -0.069% |
Comments by Wolfe_Research for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $21.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat